Nelstone Ventures — 2023 Investments

2 investments dated 2023 · listed companies and verified rows first · show all

Allermiallermi.com inSeed · Mar 2023 · $3.5M

Allermi offers custom prescription nasal sprays combining up to four active ingredients to treat nasal allergies (rhinitis), delivered via online allergist consultations and home delivery.

Digital HealthDirect to ConsumerHealthtech

Shuba Iyengar(Founder)inRobert Bocian(Founder)Shani Bocian(Founder)

PartnerRich Nelson· solo GP

Co-investorsEvolution VC Partners Lucas Venture Group Origin Ventures Headline

ClinOneclinone.comApr 2023

Needham, US

Eric Schraufnagel(Founder)inAndrea Valente(Executive Officer, Director, Promoter)

BoardSteve Lindseth(Director)Bob Conway(Director)

PartnerRich Nelson· solo GP

Co-investorsCivilization Ventures Management, Llc Hilltop Venture Partners Joyance Partners Social Starts Stout Street Capital Boulder Ventures +2 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.